trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Osteoarthritis, Knee D020370 13 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Neoplasms D009369 13 associated lipids
Intellectual Disability D008607 13 associated lipids
Radiation Injuries D011832 14 associated lipids
Brain Neoplasms D001932 15 associated lipids
Tongue Neoplasms D014062 15 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Carcinoma D002277 18 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Hosseinkhani M et al. Trichostatin A induces myocardial differentiation of monkey ES cells. 2007 Biochem. Biophys. Res. Commun. pmid:17368572
Kim HJ et al. Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. 2007 J. Pharmacol. Exp. Ther. pmid:17371805
Kitamura H et al. Down-regulation of HLA class I antigens in prostate cancer tissues and up-regulation by histone deacetylase inhibition. 2007 J. Urol. pmid:17574613
Vecsey CG et al. Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation. 2007 J. Neurosci. pmid:17553985
Pinnoji RC et al. Repressor element-1 silencing transcription factor/neuronal restrictive silencer factor (REST/NRSF) can regulate HSV-1 immediate-early transcription via histone modification. 2007 Virol. J. pmid:17555596
Kishigami S et al. Successful mouse cloning of an outbred strain by trichostatin A treatment after somatic nuclear transfer. 2007 J. Reprod. Dev. pmid:17077581
Khan Z et al. HDAC inhibition amplifies gap junction communication in neural progenitors: potential for cell-mediated enzyme prodrug therapy. 2007 Exp. Cell Res. pmid:17555745
Donadelli M et al. Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine. 2007 Biochim. Biophys. Acta pmid:17555830
Cantor JP et al. Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity. 2007 Int. J. Cancer pmid:17019711
Sakuma M et al. Promoter methylation status of the Cyclin D2 gene is associated with poor prognosis in human epithelial ovarian cancer. 2007 Cancer Sci. pmid:17270028
Kim SH et al. Regulation of the HIF-1alpha stability by histone deacetylases. 2007 Oncol. Rep. pmid:17273746
Ou JN et al. Histone deacetylase inhibitor Trichostatin A induces global and gene-specific DNA demethylation in human cancer cell lines. 2007 Biochem. Pharmacol. pmid:17276411
Hatjiharissi E et al. Proteomic analysis of waldenstrom macroglobulinemia. 2007 Cancer Res. pmid:17440091
Liu TX et al. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation. 2007 Nat. Med. pmid:17159988
Liu L and Clipstone NA Prostaglandin F2alpha inhibits adipocyte differentiation via a G alpha q-calcium-calcineurin-dependent signaling pathway. 2007 J. Cell. Biochem. pmid:16888802
Cecconi D et al. Proteomic analysis of pancreatic endocrine tumor cell lines treated with the histone deacetylase inhibitor trichostatin A. 2007 Proteomics pmid:17443844
Yoshikawa M et al. Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells. 2007 J. Am. Soc. Nephrol. pmid:17135397
Higashi T et al. Histone H2A mobility is regulated by its tails and acetylation of core histone tails. 2007 Biochem. Biophys. Res. Commun. pmid:17445770
Reddy RM et al. Rapid and profound potentiation of Apo2L/TRAIL-mediated cytotoxicity and apoptosis in thoracic cancer cells by the histone deacetylase inhibitor Trichostatin A: the essential role of the mitochondria-mediated caspase activation cascade. 2007 Apoptosis pmid:17136498
Hellebrekers DM et al. Identification of epigenetically silenced genes in tumor endothelial cells. 2007 Cancer Res. pmid:17483324
Yi T et al. Trichostatin A-mediated upregulation of p21(WAF1) contributes to osteoclast apoptosis. 2007 Exp. Mol. Med. pmid:17464183
Long JE and Cai X Igf-2r expression regulated by epigenetic modification and the locus of gene imprinting disrupted in cloned cattle. 2007 Gene pmid:17150312
Wong CM et al. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma. 2007 Hepatology pmid:17464989
Chen Y et al. Homeobox gene HOP has a potential tumor suppressive activity in human lung cancer. 2007 Int. J. Cancer pmid:17417779
Liu T et al. Design and synthesis of a potent histone deacetylase inhibitor. 2007 J. Med. Chem. pmid:17419603
Hwang CK et al. Evidence of endogenous mu opioid receptor regulation by epigenetic control of the promoters. 2007 Mol. Cell. Biol. pmid:17452465
Piotrowska H and Jagodzinski PP Trichostatin A, sodium butyrate, and 5-aza-2'-deoxycytidine alter the expression of glucocorticoid receptor alpha and beta isoforms in Hut-78 T- and Raji B-lymphoma cell lines. 2007 Biomed. Pharmacother. pmid:17498915
Berg T et al. Reversal of p15/INK4b hypermethylation in AML1/ETO-positive and -negative myeloid leukemia cell lines. 2007 Leuk. Res. pmid:17056112
Iliopoulos D et al. Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention. 2007 Ann. Rheum. Dis. pmid:17502362
Sato N et al. RhoB is frequently downregulated in non-small-cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell line. 2007 Int. J. Cancer pmid:17096327
Zhang R et al. HP1 proteins are essential for a dynamic nuclear response that rescues the function of perturbed heterochromatin in primary human cells. 2007 Mol. Cell. Biol. pmid:17101789
Ho AK et al. Acetylation of histone H3 and adrenergic-regulated gene transcription in rat pinealocytes. 2007 Endocrinology pmid:17628002
Tuncel M et al. The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake. 2007 Cancer Biother. Radiopharm. pmid:17679169
Sun DF et al. [The relationship of mTOR signaling pathway and histone acetylation in human gastric cancer cell lines]. 2007 Zhonghua Yi Xue Yi Chuan Xue Za Zhi pmid:17680526
Peng Y et al. The histone deacetylase inhibitor sodium butyrate inhibits baculovirus-mediated transgene expression in Sf9 cells. 2007 J. Biotechnol. pmid:17655959
Li YL et al. [Impact of trichostatin A on gastric carcinoma cell line SGC-7901]. 2007 Zhonghua Wei Chang Wai Ke Za Zhi pmid:17659468
Wu Y et al. The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression. 2007 Genes Cells pmid:17663720
Schneider G et al. HDAC3 is linked to cell cycle machinery in MiaPaCa2 cells by regulating transcription of skp2. 2007 Cell Prolif. pmid:17635519
Bode KA et al. Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment. 2007 Immunology pmid:17635610
Imai N et al. Inhibition of histone deacetylase activates side population cells in kidney and partially reverses chronic renal injury. 2007 Stem Cells pmid:17641247
Dai B and Rasmussen TP Global epiproteomic signatures distinguish embryonic stem cells from differentiated cells. 2007 Stem Cells pmid:17641388
Kaida D et al. Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA. 2007 Nat. Chem. Biol. pmid:17643111
Kotake Y et al. Splicing factor SF3b as a target of the antitumor natural product pladienolide. 2007 Nat. Chem. Biol. pmid:17643112
Kang JH et al. Inhibition of trichostatin A-induced antiangiogenesis by small-interfering RNA for thrombospondin-1. 2007 Exp. Mol. Med. pmid:17603295
Subramanian C et al. CREB-binding protein is a mediator of neuroblastoma cell death induced by the histone deacetylase inhibitor trichostatin A. 2007 Neoplasia pmid:17603632
Wu Y et al. Trichostatin A, a histone deacetylase inhibitor, attenuates invasiveness and reactivates E-cadherin expression in immortalized endometriotic cells. 2007 Reprod Sci pmid:17644810
Wang CT and Meng M [Experimental study on the effect of trichostatin A on differentiation of human lung carcinoma cell]. 2007 Zhonghua Yi Xue Za Zhi pmid:17650409
Janowski BA et al. Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. 2007 Nat. Chem. Biol. pmid:17259978
Oyama T et al. Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo. 2007 J. Cell Biol. pmid:17261849
Zhang L et al. Small molecule regulators of autophagy identified by an image-based high-throughput screen. 2007 Proc. Natl. Acad. Sci. U.S.A. pmid:18024584
Woo HJ et al. Induction of apoptosis and inhibition of telomerase activity by trichostatin A, a histone deacetylase inhibitor, in human leukemic U937 cells. 2007 Exp. Mol. Pathol. pmid:16574101
Park JJ et al. Functional interaction of the human cytomegalovirus IE2 protein with histone deacetylase 2 in infected human fibroblasts. 2007 J. Gen. Virol. pmid:18024889
Moiseeva EP et al. Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells. 2007 Mol. Cancer Ther. pmid:18025290
Brest P et al. Histone deacetylase inhibitors promote the tumoricidal effect of HAMLET. 2007 Cancer Res. pmid:18056459
Sourlingas TG et al. Effect of the histone deacetylase inhibitor trichostatin a in human peripheral blood lymphocytes as a function of donor age. 2007 Ann. N. Y. Acad. Sci. pmid:18056955
Ehrenkaufer GM et al. Trichostatin A effects on gene expression in the protozoan parasite Entamoeba histolytica. 2007 BMC Genomics pmid:17612405
Januchowski R et al. Trichostatin A down-regulate DNA methyltransferase 1 in Jurkat T cells. 2007 Cancer Lett. pmid:16624484
Araki H et al. Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential. 2007 Blood pmid:17185465
Mazzarelli P et al. Carnitine palmitoyltransferase I in human carcinomas: a novel role in histone deacetylation? 2007 Cancer Biol. Ther. pmid:18253084
Lee EL et al. Impaired activity of volume-sensitive Cl- channel is involved in cisplatin resistance of cancer cells. 2007 J. Cell. Physiol. pmid:17186499
Koh E et al. Trichostatin A and 5-aza-2'-deoxycytidine switch S1P from an inhibitor to a stimulator of motility through epigenetic regulation of S1P receptors. 2007 Cancer Lett. pmid:17189669
Feng W et al. Multiple histone deacetylases repress tumor suppressor gene ARHI in breast cancer. 2007 Int. J. Cancer pmid:17230502
Wu ZQ et al. Histone deacetylase inhibitor trichostatin A induced caspase-independent apoptosis in human gastric cancer cell. 2007 Chin. Med. J. pmid:18167185
Karam JA et al. The use of histone deacetylase inhibitor FK228 and DNA hypomethylation agent 5-azacytidine in human bladder cancer therapy. 2007 Int. J. Cancer pmid:17230511
Ghosh AK et al. Trichostatin A blocks TGF-beta-induced collagen gene expression in skin fibroblasts: involvement of Sp1. 2007 Biochem. Biophys. Res. Commun. pmid:17234156
Shimazu T et al. Multiple histone deacetylases and the CREB-binding protein regulate pre-mRNA 3'-end processing. 2007 J. Biol. Chem. pmid:17172643
Januchowski R and Jagodzinski PP Trichostatin A down-regulates ZAP-70, LAT and SLP-76 content in Jurkat T cells. 2007 Int. Immunopharmacol. pmid:17178387
Cras A et al. Epigenetic patterns of the retinoic acid receptor beta2 promoter in retinoic acid-resistant thyroid cancer cells. 2007 Oncogene pmid:17213810
Frye M et al. Epidermal stem cells are defined by global histone modifications that are altered by Myc-induced differentiation. 2007 PLoS ONE pmid:17712411
Adcock IM et al. Epigenetic regulation of airway inflammation. 2007 Curr. Opin. Immunol. pmid:17720468
Zhang Y et al. Attenuated DNA damage repair by trichostatin A through BRCA1 suppression. 2007 Radiat. Res. pmid:17722998
Zhou X et al. The interferon-alpha responsive gene TMEM7 suppresses cell proliferation and is downregulated in human hepatocellular carcinoma. 2007 Cancer Genet. Cytogenet. pmid:17693185
Zhong S et al. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer. 2007 Oncogene pmid:17043644
Han S et al. HDAC inhibitors TSA and sodium butyrate enhanced the human IL-5 expression by altering histone acetylation status at its promoter region. 2007 Immunol. Lett. pmid:17270283
Wang F et al. Dynamic reprogramming of histone acetylation and methylation in the first cell cycle of cloned mouse embryos. 2007 Biol. Reprod. pmid:17823087
Katz RA et al. High-frequency epigenetic repression and silencing of retroviruses can be antagonized by histone deacetylase inhibitors and transcriptional activators, but uniform reactivation in cell clones is restricted by additional mechanisms. 2007 J. Virol. pmid:17202206
De los Santos M et al. Combined effects of retinoic acid and histone deacetylase inhibitors on human neuroblastoma SH-SY5Y cells. 2007 Mol. Cancer Ther. pmid:17431121
Qi J et al. [Hypermethylation and regulation of expression of secreted frizzled-related protein genes in colorectal tumor]. 2007 Zhonghua Zhong Liu Za Zhi pmid:18396643
Pourebrahim R et al. ZIC1 gene expression is controlled by DNA and histone methylation in mesenchymal proliferations. 2007 FEBS Lett. pmid:17936758
Sichtig N et al. Papillomavirus binding factor binds to SAP30 and represses transcription via recruitment of the HDAC1 co-repressor complex. 2007 Arch. Biochem. Biophys. pmid:17897615
Charrier C et al. Antiproliferative activities of a library of hybrids between indanones and HDAC inhibitor SAHA and MS-275 analogues. 2007 Bioorg. Med. Chem. Lett. pmid:17897824
Li T and Chiang JY A novel role of transforming growth factor beta1 in transcriptional repression of human cholesterol 7alpha-hydroxylase gene. 2007 Gastroenterology pmid:17920062
Tao R et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. 2007 Nat. Med. pmid:17922010
Qi J et al. [The role of secreted Wnt-antagonist genes hypermethylation in early detection of colorectal tumor]. 2007 Zhonghua Yi Xue Za Zhi pmid:17923031
Pulukuri SM et al. Inhibition of histone deacetylase activity promotes invasion of human cancer cells through activation of urokinase plasminogen activator. 2007 J. Biol. Chem. pmid:17923479
Stapnes C et al. Functional characteristics and gene expression profiles of primary acute myeloid leukaemia cells identify patient subgroups that differ in susceptibility to histone deacetylase inhibitors. 2007 Int. J. Oncol. pmid:17982680
Honda H et al. Regulation of the CLDN3 gene in ovarian cancer cells. 2007 Cancer Biol. Ther. pmid:17986852
Renthal W et al. Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. 2007 Neuron pmid:17988634
Carén H et al. Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumours. 2007 Br. J. Cancer pmid:17940511
Shivashimpi GM et al. Molecular design of histone deacetylase inhibitors by aromatic ring shifting in chlamydocin framework. 2007 Bioorg. Med. Chem. pmid:17881232
Terry-Allison T et al. Relaxed repression of herpes simplex virus type 1 genomes in Murine trigeminal neurons. 2007 J. Virol. pmid:17855552
Putnik J et al. The interaction of ETV6 (TEL) and TIP60 requires a functional histone acetyltransferase domain in TIP60. 2007 Biochim. Biophys. Acta pmid:17980166
Kuljaca S et al. Enhancing the anti-angiogenic action of histone deacetylase inhibitors. 2007 Mol. Cancer pmid:17958916
Wee G et al. Epigenetic alteration of the donor cells does not recapitulate the reprogramming of DNA methylation in cloned embryos. 2007 Reproduction pmid:18042635
Barr H et al. Mbd2 contributes to DNA methylation-directed repression of the Xist gene. 2007 Mol. Cell. Biol. pmid:17353271
Li B et al. FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. 2007 Proc. Natl. Acad. Sci. U.S.A. pmid:17360565
Vandergeeten C et al. HIV-1 protease inhibitors do not interfere with provirus transcription and host cell apoptosis induced by combined treatment TNF-alpha + TSA. 2007 Biochem. Pharmacol. pmid:17386923
Rohner A et al. Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis. 2007 Leuk. Res. pmid:17391757
Dompierre JP et al. Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. 2007 J. Neurosci. pmid:17392473
Hashii M et al. Up-regulation of ras-GAP genes is reversed by a MEK inhibitor and doxorubicin in v-Ki-ras-transformed NIH/3T3 fibroblasts. 2007 Biochem. Biophys. Res. Commun. pmid:17367762